In preclinical model systems, the fundamental principles underlying a successful and durable anti-tumour immune response are well demonstrated.

In the past two decades, immunotherapy of cancer has developed into an established treatment option. At first, the development of monoclonal antibodies…

There have been significant technological and technical advances in radiotherapy over the last 20 years. This paper presents the pertinent advances and…

The scientific basis for the surgical management of patients with glioma is rapidly evolving. The infiltrative nature of these cancers precludes a…

Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the…

Last week I had the opportunity to attend a small breakfast meeting where the speaker was Dr Catherine Mohr. Dr Mohr is an extraordinary individual…

This Takeda-sponsored European Association for the Study of Diabetes (EASD) symposium addressed the pharmacology, clinical use, and future therapeutic…

Individuals with Type 1 diabetes mellitus (T1DM) are required to carefully manage their insulin dosing, dietary intake, and activity levels in order to…

The prevalence of Type 2 diabetes mellitus (T2DM) has reached epidemic proportions in recent years. It is now widely recognised that T2DM…